David J. Gullen
Directeur/Membre du Conseil chez Translational Genomics Research Institute
Profil
David J.
Gullen is currently the Director at the Translational Genomics Research Institute and the Director at the Flinn Foundation.
He has a graduate degree from Arizona State University, an undergraduate degree from Princeton University, and a doctorate degree from the University of Arizona.
Postes actifs de David J. Gullen
| Sociétés | Poste | Début |
|---|---|---|
Translational Genomics Research Institute
 Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | - |
Flinn Foundation
 Flinn Foundation Investment Trusts/Mutual FundsMiscellaneous Flinn Foundation engages as a philanthropic grantmaking organization. It helps in the advancement of the state's bioscience sector and provides education to high-achieving students at an Arizona public university. The company was founded by Robert S. Finn and Irene Flinn in 1965 and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | 30/03/2023 |
Formation de David J. Gullen
| University of Arizona | Doctorate Degree |
| Arizona State University | Graduate Degree |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
Flinn Foundation
Flinn Foundation Investment Trusts/Mutual FundsMiscellaneous Flinn Foundation engages as a philanthropic grantmaking organization. It helps in the advancement of the state's bioscience sector and provides education to high-achieving students at an Arizona public university. The company was founded by Robert S. Finn and Irene Flinn in 1965 and is headquartered in Phoenix, AZ. | Miscellaneous |
